Literature DB >> 6698641

The serologically unique cell surface antigen of Zajdela ascitic hepatoma is also its tumor-associated transplantation antigen.

P K Srivastava, M R Das.   

Abstract

A unique cell surface antigen of a chemically induced rat hepatoma (Zajdela Ascitic Hepatoma, ZAH) has been identified serologically and purified to apparent homogeneity. ZAH cells, when injected subcutaneously or intradermally into syngeneic hosts, elicit a weak humoral antibody response directed against a single cell surface antigen. In spite of prolonged and extensive immunization, the syngeneic anti-tumor antibodies are solely of the IgM class. Antisera from such immunized animals lyse tumor cells in the presence of complement. These observations were utilized in developing methods for the identification and purification of the antigen. It was observed that administration of purified preparations of this antigen confers ZAH-specific tumor immunity in syngeneic animals. Hence the serologically unique antigen is also the tumor-associated transplantation antigen (TATA) of this tumor. This is the first reported purification of a TATA from a rat tumor. There is considerable earlier evidence for the existence of tumor-associated factors which elicit a strong suppressor-cell response in tumor-bearing rats. The availability of the purified TATA from a rat tumor provides, for the first time, a handle for the identification and further characterization of such molecular species.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6698641     DOI: 10.1002/ijc.2910330321

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  17 in total

1.  Expression of heat-shock protein gp96 in gallbladder cancer and its prognostic clinical significance.

Authors:  Yongli Chen; Chuanqi Chen; Chengzhi Ma; Shibo Sun; Jing Zhang; Yan Sun
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

2.  Natural autoantibodies against heat-shock proteins hsp70 and gp96: implications for immunotherapy using heat-shock proteins.

Authors:  A Ménoret; R Y Chandawarkar; P K Srivastava
Journal:  Immunology       Date:  2000-11       Impact factor: 7.397

3.  Chromosomal assignment of the gene encoding the mouse tumor rejection antigen gp96.

Authors:  P K Srivastava; C A Kozak; L J Old
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

4.  Identification of chaperones as essential components of the tumor rejection moieties of cancers.

Authors:  Pramod K Srivastava
Journal:  Cancer Immun       Date:  2012-05-01

5.  Fusion proteins of Hsp70 with tumor-associated antigen acting as a potent tumor vaccine and the C-terminal peptide-binding domain of Hsp70 being essential in inducing antigen-independent anti-tumor response in vivo.

Authors:  Honghai Zhang; Weida Huang
Journal:  Cell Stress Chaperones       Date:  2006       Impact factor: 3.667

Review 6.  Heat shock proteins transfer peptides during antigen processing and CTL priming.

Authors:  P K Srivastava; H Udono; N E Blachere; Z Li
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

7.  Glucose-regulated protein 94 modulates the therapeutic efficacy to taxane in cervical cancer cells.

Authors:  Cheng-Jeng Tai; Jin-Wun Wang; Hou-Yu Su; Chen-Jei Tai; Chien-Kai Wang; Chun-Te Wu; Yung-Chang Lien; Yu-Jia Chang
Journal:  Tumour Biol       Date:  2013-08-09

Review 8.  Heat shock proteins in immune response to cancer: the Fourth Paradigm.

Authors:  P K Srivastava
Journal:  Experientia       Date:  1994-11-30

9.  5'-structural analysis of genes encoding polymorphic antigens of chemically induced tumors.

Authors:  P K Srivastava; Y T Chen; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

Review 10.  Therapeutic cancer vaccines: using unique antigens.

Authors:  Jonathan J Lewis
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.